(123)i-meta-iodobenzylguanidine
(123)i-mibg
1-alkyl-2-acetyl-sn-glycerol cholinephosphotransferase
2-way anova
6 min walk test
6-min walk test
6-minute hall walk
6-minute walk distance
6-minute walk test
6-minute walked distance
6-minute walking distance
6-mwt
6mwt
8-fluo-camp
a comparison of outcomes in patients in new york heart association [nyha] class ii heart failure when treated with eplerenone or placebo in addition to standard heart failure medicines
aa
abcc2
abdominal
ablation
absorptiometry
acetylcholinesterase inhibitor
adenoviral
adjuvant
adrenergic
adrenomedullin
adverse outcome
aetiologies
akt→forkhead box class o-1 signaling
alberta
aldactone
aldosterone receptor
all-cause hospitalisations
all-cause hospitalization
all-cause hospitalizations
all-cause readmission
all-cause readmissions
alphalisa
amyloidotic
anabolic
anaerobic metabolism
anastomosis
anesthetized
ang ii
angeli's salt
angiotensin
angiotensin converting enzyme
angiotensin ii  infusion
angiotensin receptor antagonist
angiotensin-converting enzyme
ann arbor veterans' affairs
antagonism
antagonist
antagonists
anterior leaflet
anti-inflammatory
antiadrenergic
antiarrhythmic
antitumor
aor
aortic
aortic insufficiency
aortic pressure
aortic valve
aortic valve insufficiency
apex
area under the curve
area under the receiver operating characteristic curve
arg16/gln27
arg76
arterial
arteries
artery
artery tonometry
arthritis
asymptomatic
at1
atherosclerotic
atpase
atrial
atrial explants
atrial natriuretic peptide
atrioventricular
atrium
attrition
autonomic nervous system
b natriuretic peptides
b-type natriuretic peptides
b-type np
baroreflex
baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction
benign tumors
beta-blocker
biomedical
biopsies
biopsy
blood
blood cell
blood flow
blood glucose
blood-flow
bolus
bone morphogenetic protein 4
bpm
bradyarrhythmias
bradycardia
bradycardic
brain
bromodomain
bromodomain-containing protein 4
btt
bundle branch morphology
bypass
c statistics
c-kit+ progenitors
c-terminally
ca(2+)
ca(2+) handling
ca(2+) sensitivity
ca2(+)
ca2+
cabg
california
california office of statewide health planning and development patient discharge data nonpublic file
canada
candesartan
carcinoma
cardiac deaths
cardiac defibrillator
cardiac energy metabolism gene expression
cardiac magnetic resonance postcontrast t1 time
cardiac mrna
cardiac overexpression
cardiac plasma membrane
cardiac sodium
cardiac transplants
cardiac volume
cardiac volume overload
cardiogenic
cardiography
cardiomyiopathy
cardiomyocyte
cardiomyopathic
cardiomyopathies
cardiopulmonary
cardiovascular outcomes in renal atherosclerotic lesions
cardiovascular reserve
cardioverter-defibrillator
caspase
caspase 3
catabolic
catecholamine
catecholamines
catheter
catheterisation
cd133+ cells
cd34+vegfr2+ cells
cell death
central glycosylated region
centre for reviews and dissemination
centrimag
cerebral
cerebrovascular
cfi
cgmp
cgmp synthesis
chagas' disease
chamber
charm
cha₂ds₂vasc score
chelation
chest
cholesterol
chronic
chronic advanced heart failure
chronic thromboembolic pulmonary hypertension
chronotropic response
circulatory
circumflex artery
cis
clcnka
clinically
clinician
cluster analysis
cochrane effective practice and organisation of care taxonomy
cohort studies
cohort study
collagen
collins
combined end point
comorbid
comorbidity
complication
complications
composite end point
composite end-point
composite primary outcome
condition
confidence intervals
congenital
connecticut
consultation
consultations
contemporaneous control group
continuity equation
continuous wave doppler echocardiography
contracting
cooper center longitudinal study
coprimary outcome
coronary
coronary artery
coronary artery bypass
coronary revascularization
correlate
correlated
correlates
correlation
correlations
covariate
covariate adjustment
covariates
cox proportional hazard analyses
cox proportional hazards analyses
cox regression analysis
creatine
cronbach's α
cross talk
crossover study
curative
cxl-1051
cyclase
cystatin c
cytoskeleton
cytotoxic
dapc protein
dash/srd
decompensated heart failure
decompensated hf
decompensated systolic heart failure
decompensation
defibrillation
defibrillators
degenerative mitral regurgitation
degenerative mitral valve
denervation
descriptive statistics
dhand
diagnosed
diagnoses
diagnosis
diastolic filling formalism
diastolic mitral annulus velocity
diastolic stiffness
diastolic tethering
dietary approaches to stop hypertension
differential analysis
differentially expressed genes
dilatation
dilated
dilation
discharges
diseased
diseases
doppler
downregulated
downstream signaling
doxorubicin efflux transporter
dpp-4 inhibitors
driveline
drs
dual x-ray absorptiometry
duke activity status index
e/e'
early treatment of atrial fibrillation for stroke prevention trial
ecgs
echo-doppler
edema
effector molecules
ehrlich carcinoma
electrocardiogram
electrocardiographic q waves
embolectomy
embolize
emergency room
end point
end points
end-diastolic
end-point
end-systolic
endopeptidase
endopeptidase inhibitors
endpoint
endpoints
enos-ser(1177)
enos-thr(495)
enzyme
enzymes
epicatechin
eplerenone post myocardial infarction heart failure efficacy and survival study
erk1/2
erythropoiesis
erythropoiesis-stimulating agent
estimated glomerular filtration rate
euthanization
evidence based practice centres
evidence-based
explant
explanted
exploratory factor analysis
expressions
extended criteria cardiac transplant
extended criteria cardiac transplantation
extra corporeal membrane oxygenation
extracellular
extracorporeal life support
extracorporeal support
fibrillation
fluorescence resonance energy transfer
follow up
follow-up duration
followed up
followed-up
fpassive
fractional flow reserve
framingham heart study
fully magnetically levitated centrifugal-flow chronic lvas
fully magnetically levitated left ventricular assist system
functional class
functional enrichment analysis
functional status
furosemide
g-protein coupling
g-protein-coupled receptor
gadolinium-chelate
gastrointestinal
gata4
gene induction
general anaesthesia
genomic
genomic reprogramming
genotype
genotyped
get with the guideline-heart failure registry
get with the guidelines-heart failure
global gene expression
glucocorticoid
glucocorticoids
gly16/glu27
gly4
gly7
grade 4/6 holosystolic murmur
grading of recommendations assessment, development and evaluation
gtpase
guanylate cyclase
guideline-directed medical therapy
haematopoietic
haplotype
health abc hf model
health abc hf risk model
health care
health-care
healthcare common procedure coding system codes
healthy
heart  failure
heart failure - a controlled trial investigating outcomes in exercise training
heart failure and reduced ejection fraction
heart failure with a reduced ejection fraction
heart failure with preserved ejection fraction
heart failure with preserved left ventricular ejection fraction
heart failure with reduced ejection fraction
heart failure: a controlled trial investigating outcomes of exercise training
heart muscle
heart sound
heart-specific irs1 and irs2 gene double-knockout
hemocompatibility
hemodynamic phenotype
hemodynamics
hemolysis
hepatic
hf with preserved ef
hf with preserved ejection fraction
hf with reduced ef
hf with reduced ejection fraction
hhd
histologically
homozygous
hospital compare
human induced pluripotent stem cell-derived cardiomyocytes
human-to-human contact
hvad
hypertensive heart failure with preserved ejection fraction
hypertrophic
hypertrophied
hypothermic circulatory arrest
idiopathic
immunoreactive
implantable
implantable cardioverter defibrillator
implantations
implanted
implants
in vitro
in vivo
incremental shuttle walk test
infarcted
infarction
infection
inferior vena cava
infusion
infusions
ingenuity pathway analysis
inhospital
injected
inoperable
insignificantly
insulin receptor substrates 1
insulin-resistance
integrated discrimination improvement
intensive care
intensive care unit
intention-to-treat
interaction term analysis
interatrial
interatrial shunt
interatrial shunting
interleukin receptor
interventricular
interventricular septum
intestinal
intracellular
intraclass correlation coefficient
intravenous
intravenous bolus
intravenously
intubation
invasive
invasively
inverse correlation
ischaemia
ischemic hf
ischemic-hypertensive cardiomyiopathy
isoforms
isolated coronary artery bypass grafting
israel
joanna briggs institute evidence based practice
jugular
kaiser permanente
kansas city
kaplan-meier analyses
kidney
kidney disease
kinase
kinase-2
kv4.3
l-type ca2(+) current
l-type ca2+ currents
l-type channel
lcz696
lean mass quantification
left anterior descending artery
left atrial
left atrial pressure
left bundle-branch block
left pulmonary artery
left ventricular dd
left ventricular function
left ventricular hypertrophy
lesion
lesions
leu3
leukocytes
linear mixed models
linear models
lipid
lipoprotein
liver
liver-specific irs1 and irs2 double-knockout
log rank
lokomat
longitudinal
lung
lv end-diastolic dimension
lv end-diastolic pressure
lv end-diastolic volume
lv filling pressure
lv posterior wall
lv relaxation
madit-crt
magnet
malondialdehyde
mapk
mass spectrometric analysis
massive embolism
maximal ventricular power index
maximum oxygen consumption
mdc
medicaid
medical outcomes study short-form
medically
medicine
medicines
mena deletion
mesenchymal
meta-analyses
meta-analysis
meta-analyzed
mets
michigan
microembolization
mild hf
minimal detectable change
minnesota quality of life
mis
mitochondrial complex v activity
mitochondrial proteome
mitochondrial-targeted peptide
mitogen-activated protein kinase
mitral
mitral annular velocity
mitral annulus velocity
mitral leaflet motions
mitral valve
mixed linear models
mixed models
mixed-methods study
mlhf questionnaire
molecular scaffolds
morbidities
morpholino-based
mpsms
mri
mrna splice
mrnas
multicenter automatic defibrillator implantation with cardiac resynchronization therapy
multivariable adjustment
multivariable analysis
multivariable logistic analysis
multivariable models
multivariable regression
multivariate analyses
multivariate analysis
multivariate cox model
multivariate cox proportional hazards regression modeling
multivariate cox regression analyses
multivariate logistic regression analysis
multivariate model
multivariate models
multivariate regression
multivariate-adjusted odds ratio
murine
muscle
muscles
muscular
myocardial
myoctyes
myocyte-specific mena overexpression
myofibre regeneration
myofibrillar
myosin
myxoma
n-terminal pro-b-type np
n-terminal pro-brain-type natriuretic peptide
n2bus
na+ channel
na+ channel α-subunit
na+ channels
nad(p)h-oxidase
nanog
nanomolar
narrow qrs complex
natriuretic
ncdr pinnacle
neprilysin
neprilysin inhibitor
neuro-hormonal
neurohormonal
neurohormonal systems
neurohormonally
neurohumoral
new york heart association class i
new york heart association class ii
new york heart association class iii
new york heart association classes
new york heart association classification
new york heart association functional class
new zealand
nfat
nitrite
non-biological disease modifying antirheumatic drug
non-cachectic chf
non-invasively
noncardiovascular
nondiabetes
noninvasive
nonischemic
nonmitochondrial
nonselective β-blocker
nonsignificant
nontrastuzumab users
northern california
nosignificant
nt-pro bnp
nurse
nurse practitioner
nyha class iii
nyha functional class
nyha functional class ii
nyha functional class iii
nyha functional class iv
nyha-iii
observational cohort studies
observational cohort study
oedema
ontario
operative
or
oral
orally
organ
organ failure
out-patient
outpatient
p
p value
p values
p-value
p.arg83gly
p38alpha
p38α
p70s6k-ser(411)
paf-acetylhydrolase
palliation
palliative
parasympathetic
partial pressure of end-tidal co2
pathological
pathology
pathophysiologic
patient
paucity
pde
pdrelated
peak o2
peak respiratory quotient
pediatric fontan
peptide
peptides
perceived social support score
percutaneous
periodic breathing
peripheral muscle
phenotype
phenotypes
phosphomimic
physical examination
physiologic
physiological
physiology
pkc-βii-ser(660)
plasma b-type natriuretic peptide
pluripotency marker
pluripotency markers
poc
point of care
point-of-care
polymerase ii
polymorphism
polymorphisms
polytetrafluoroethylene
positron emission tomography
post hoc analysis
post-myocardial infarction
postmenopausal
postoperative
preoperative
prescribed
prescription
preserved ef
preserved left ventricular ejection fraction
preserved left ventricular ejection fractions
preserved lv ejection fraction
preserved lvef
pressure-overload
prevalence
primary composite endpoint
primary end point
primary outcomes
pro bnp
pro-b-type natriuretic peptide
pro-b-type natriuretic peptides
pro-b-type np
pro-brain natriuretic peptide
pro-brain-type natriuretic peptide
pro2
pro6
pro75
proangiogenic
proanp
probnp
prodrug
progenitor
progenitor cells
progenitors
prognosis
prognostically
propensity score
propensity-score
prospective
prospective studies
prospective study
prospectively
protein kinase a
protein kinase r-like er kinase
protein-c
proteolysis
proteomic
psychometric
psychosocial
pulmonary arterial systolic pressure
pulmonary artery systolic pressure
pulse
pulse-wave
q65p
qt interval
quality-of-life
r
r-r interval
rac1
rac2
rad variant
random-effects models
randomised
randomize
randomized
rankin score
ras-blocker
rate ratio
rcts
red blood cell
red blood cell transfusion
reduced ef
reduced left ventricular ejection fraction
refractory right heart failure
regression analyses
regression line
regression modeling
regression models
renal disease
renin
renin inhibitors
reperfusion
repolarization
respiratory gas analysis
resting tension
resuscitation
resynchronization
resynchronization reverses remodeling in systolic left ventricular dysfunction
resynchronization therapy
retrospective cohort
retrospective cohort study
retrospective matched cohort study
rgk
rheumatoid
rhythm control
right atrial
right pulmonary artery
right ventricular assist device
right ventricular contractile function
right ventricular end-diastolic area index
right ventricular fractional area
rna
rnas
rs10927887
rv decompensation
rv function
rv support
s'
s1pr1 agonist
scaffold protein
scaffold proteins
schfi v.6.2
sd of all qt intervals
sd of rr intervals
sdrr
seattle
secondary end point
secondary end points
secondary endpoints
secondary outcome
secondary outcomes
selective beta-blockers
selective β-blocker
self-care confidence
self-care maintenance
self-care of heart failure index version 6.2
sensitivity
ser96
serum albumin
serum creatinine
serum sodium
severe hf
severe systolic heart failure
shotgun lc-ms/ms
shunt
shunting
signal transduction
signalling pathway
signalosome complex
significance
significant
significantly
smad 2/3
snp
sonographic
specificity
sphingosine-1-phosphate receptor 1
sprague-dawley
stable
stable heart failure
stable hf
stem cell
stenosis
stenotic physiology
sternal
stroke volume index
structured telephone support
student t test
subcellular
subclinical
subproteome
subproteomes
surgeons
surgical
surgically
sweden
sympathetic control of heart rate
symptom
symptomatic adult fontan
symptomatic chronic advanced heart failure
symptoms
syndromes
systemic
systolic  heart failure
systolic heart failure treatment with the if inhibitor ivabradine trial
systolic volume index
t1 time
t1 times
t1-mapping
t2*
tachyarrhythmias
tachycardic
terminal
testosterone supplementation
texas
texas cancer registry–medicare
tgf-β
tgf-β receptor type i
tgf-β signaling
thalassaemia major
the chronic kidney disease epidemiology collaboration
the danish heart failure database
the lancet
therapeutics
thr197
thromboembolic
thromboembolic pulmonary hypertension
thromboembolism
thrombotic
tissue doppler
tissuefaxs
titrated
tm24/7
tomographic angiography
tonometry
tools for economic analysis of patient management interventions in heart failure cost-effectiveness model
total arterial compliance
transmitral
transmitral blood flow velocity
transmitral flow
transplantations
transseptal
trichrome blue histologic analysis
tricuspid
tricuspid annular plane
troponin
troponin i
trpm7
tta/tgtetmena
tug
tumor
tumors
tunel
type i regulatory subunit
u.s. food and drug administration's mini-sentinel
ulcers
undiagnosed
unilateral renal denervation
univariable analysis
univariate analysis
university of connecticut
uptitrations
us
use of exercise and medical therapies to improve cardiac function among patients with exertional shortness of breath due to lung congestion
valvular regurgitation
vascular
vascular disease
vasodilator
vasodilatory
vasopressin type 2 receptor antagonist
vegf
vegf expression
ven/vco2 slope
venous
venous thromboembolic events
ventricle
ventricles
ventricular action potential
ventricular fibrillation
ventricular function
ventricular myocytes
ventricular systolic hf
ventricularly
vo2 max
wall stiffness
wide qrs complex
wilcoxon matched-pairs signed-rank tests
x-ray
yorkshire
zsf1
β coefficient
β-adrenergic receptor
β-adrenergic receptor blocker
β2-receptor haplotype
